Functional evaluation of therapeutic response for a mouse model of medulloblastoma

By Samano Aislynn  

Transgenic Research, Vol. 19, Iss. 5, 2010-10 ,pp. : 829-840

Springer Publishing Company

Access to resources Recommend Favorite

Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach

By Hay David G.   Sathasivam Kirupa   Tobaben Sönke   Stahl Bernd   Marber Michael   Mestril Ruben   Mahal Amarbirpal   Smith Donna L.   Woodman Ben   Bates Gillian P.  

Human Molecular Genetics, Vol. 13, Iss. 13, 2004-07 ,pp. : 1389-1405

Oxford University Press

Access to resources Recommend Favorite

Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex

By Anderl Stefanie   Freeland Megan   Kwiatkowski David J.   Goto June  

Human Molecular Genetics, Vol. 20, Iss. 23, 2011-12 ,pp. : 4597-4604

Oxford University Press

Access to resources Recommend Favorite

Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease

By Perry Giselle M.   Tallaksen-Greene Sara   Kumar Ashish   Heng Mary Y.   Kneynsberg Andrew   van Groen Thomas   Detloff Peter J.   Albin Roger L.   Lesort Mathieu  

Human Molecular Genetics, Vol. 19, Iss. 17, 2010-09 ,pp. : 3354-3371

Oxford University Press

Access to resources Recommend Favorite

Mouse model of muscleblind-like 1 overexpression: skeletal muscle effects and therapeutic promise

By Chamberlain Christopher M.   Ranum Laura P.W.  

Human Molecular Genetics, Vol. 21, Iss. 21, 2012-11 ,pp. : 4645-4654

Oxford University Press

Access to resources Recommend Favorite